{"id":"W2769831433","doi":"10.2147/ndt.s150589","title":"The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone","year":2017,"lang":"en","type":"review","venue":"Neuropsychiatric Disease and Treatment","topic":"Treatment of Major Depression","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Allergan","keywords":"Vortioxetine; Medicine; Discontinuation; Major depressive disorder; Antidepressant; Serotonin reuptake inhibitor; Tolerability; Nausea; Partial agonist; Placebo; Serotonergic; Adverse effect; Psychiatry; Internal medicine; Mood; Anxiety; Serotonin; Agonist; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00312911,0.0006714144,0.001709802,0.009032094,0.001125137,0.003051088,0.001168466,0.001662035,0.003855541],"category_scores_gemma":[0.009679335,0.000520614,0.001209523,0.01289582,0.0009566899,0.001590232,0.0009510208,0.001626556,0.0003616776],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0191094,"about_ca_system_score_gemma":0.06155085,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.5303904,"about_ca_topic_score_gemma":0.7483554,"domain_scores_codex":[0.9974713,0.0004301194,0.0006629443,0.0002093619,0.001033727,0.0001924931],"domain_scores_gemma":[0.9853059,0.005014123,0.001874314,0.00009348975,0.006927978,0.0007841549],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002109594,0.00007011243,0.002324749,0.1317113,0.000343431,0.0002971767,0.0007588343,0.0003842524,0.0003167159,0.002387616,0.04083115,0.8203638],"study_design_scores_gemma":[0.0001342569,0.0002936855,0.03146055,0.2059155,0.001830403,0.001336945,0.001540811,0.0004705028,0.0002356368,0.0008151319,0.7558303,0.0001362708],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002024413,0.9980398,0.00002263794,0.001065502,0.0001498549,0.000009955351,0.00006247513,0.000002711393,0.0004446905],"genre_scores_gemma":[0.001616932,0.9975249,0.0001321886,0.0004416799,0.0001040098,0.00001160054,0.0000525414,0.000001403756,0.000114717],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4696096,"threshold_uncertainty_score":0.9447504,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05069139812595359,"score_gpt":0.3892445612285179,"score_spread":0.3385531631025643,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}